Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GEMIN7 pseudogene 1 (GEMIN7P1) is a molecular sequence in the human genome classified as a pseudogene—meaning it shares high homology with the protein-coding GEMIN7 gene but has been rendered nonfunctional by mutations and/or lost regulatory elements[4]. Pseudogenes like GEMIN7P1 do not encode functional proteins but may participate in cellular regulation by acting as competing endogenous RNAs, mainly through sequestration of microRNAs, thereby influencing the expression of other genes[3][4]. While some pseudogenes have been implicated in cancer and other diseases via RNA-level effects, there is no documented evidence that GEMIN7P1 is a conventional drug target or has direct associations with specific disease processes[2][3]. Queries about GEMIN7P1 as a receptor or therapeutic target reflect a category error, as its biological roles are distinct and indirect compared to active receptor, enzyme, or transporter molecules.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GEMIN7 pseudogene 1 (GEMIN7P1).